Third-line therapies in patients with Kawasaki disease refractory to first- and second-line intravenous immunoglobulin therapy.
World J Pediatr
; 18(11): 781-785, 2022 11.
Article
in En
| MEDLINE
| ID: mdl-35976528
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Mucocutaneous Lymph Node Syndrome
Type of study:
Diagnostic_studies
Limits:
Humans
/
Infant
Language:
En
Journal:
World J Pediatr
Journal subject:
PEDIATRIA
Year:
2022
Document type:
Article
Affiliation country:
Japón